What is Bio Process Technology Market?
Bioprocessing technology is used for the production of pharmaceuticals, foods, flavors, fuels, and chemicals with the aid of a biocatalyst such as an enzyme, microorganisms, plant cell, or animal cell in a bioreactor. Bioprocess technology has the industrial application of biological processes involving living cells or their components to effect the desired transformation of substrates. Upsurge in demand for, personalized treatment for diseases such as cancer is intensifying the demand for various bioprocess therapies, including cell therapy.
Highlights from Bio Process Technology Market Study
|Unit||Value (USD Million)|
|Key Companies Profiled||GE Healthcare (United States), Danaher Corporation (United States), Thermo Fisher Scientific (United States), Cytiva (United States), Repligen (United States), Eppendorf (Germany), Boehringer Ingelheim (Germany), Sartorius Stedim Biotech S.A (Germany), Merck Millipore (Germany) and MilliporeSigma (United States)|
The global Bioprocess Technology market is fragmented due to the Advancement in bioprocess technology. So the players are focusing on the market expansion by both inorganic and organic approaches and increasing the feature and performance of larger bioreactors. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions and it maintains their growth at the competitive edge. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Bio Process Technology market throughout the forecasted period. GE Healthcare (United States), Danaher Corporation (United States), Thermo Fisher Scientific (United States), Cytiva (United States), Repligen (United States), Eppendorf (Germany), Boehringer Ingelheim (Germany), Sartorius Stedim Biotech S.A (Germany), Merck Millipore (Germany) and MilliporeSigma (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Univercells (Belgium), Emerson Electric Co. (United States) and Abbott (United States).
Bio Process Technology Market Segmentation:
|Application / End User||Biopharmaceuticals, Chemical Industry and Others|
|Type||Batch, Fed-batch, Continuous Fermentation and Others|
|Technology||Gene Therapy,Cell Therapy,Others|
On the basis of geography, the market of Bio Process Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Prevalence of chronic disease
- Rise in the infectious diseases and continuous development in the bioprocess technology
- Expansion in the Biopharmaceutical industry
- Growing Demand for Bioprocessing technology For Cellular and Gene Therapy
- Technological Advancement in the BioProcess Technology
- Rapid Development of High-Productivity Upstream Processes
- High cost associated with the BioProcess Technology
- Growing Opportunity in the Biopharmaceutical industry across the Globe
- Increasing New Production Sites and Expansion of Existing Sites in Emerging Countries
- Concerns related to optimization of cell culture media formulation
Market Leaders & Development Strategies
On 1st July 2020, Merck the leading science and Technology Company announced the acquisition of RESOLUTION Spectra Systems, which leads to the enhancement of its advanced bioprocess portfolio. This acquisition supports the vision of delivering intensified, connected, and continuous bioprocessing and validates the strategy to support process analytical technology implementation as a key element of biopharmaceutical industry digitalization.
On 28th September 2021, Refine Technology, LLC is most known for the development of the ATF system for cell culture perfusion, which is promoting its new CORe mini bioreactor system and cleanliness 1.5 single-use connector at the bioprocess international virtual conference 2021. The CORe mini bioreactor system is a compact device that has all the features and performance of larger bioreactors. Suspension cells may be cultured with CORe system with applications in the field of R&D, process development, personalized medicine and stem culture applications. CORe system is designed for the use with the pre-sterilized, single-cell culture vessels, The system contains the eight peristaltic pumps and offers four gas control as well as a variety of vessels configuration for making an addition, subtraction, sampling, perfusion and other adaptation customized
Key Target AudienceBioProcess Technology Providers, Regulatory Bodies, New Entrants, Potential Investors, Research and Development Institutes and Others
Frequently Asked Questions (FAQ):
Which factors would majorly drive the Bio Process Technology Market?
"Increasing Prevalence of chronic disease
" is seen as one of major growth factors of Bio Process Technology Market in years to come.
Can we have customized study for Bio Process Technology Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Which region will lead the Global Bio Process Technology Market?
United States will lead Bio Process Technology Market in coming years.
Why are some of the known companies left out of the Bio Process Technology Market report?
The Bio Process Technology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.